His-tag binding by antibody C706 mimics β-amyloid recognition

Journal of Molecular Recognition

Volumn 24, Issue 4, 2011, Pages 570-575

  Teplyakov, Alexey ^a   Obmolova, Galina ^a   Canziani, Gabriela ^a   Zhao, Yonghong ^a   Gutshall, Lester ^a   Jung, Sonia S ^a   Gilliland, Gary L ^a  

^a CENTOCOR INC   (United States)

Author keywords

amyloid; Alzheimer's disease; crystal structure; monoclonal antibody

Indexed keywords

AMYLOID BETA PROTEIN; MONOCLONAL ANTIBODY;

ALZHEIMER DISEASE; ARTICLE; CHEMISTRY; HUMAN; METABOLISM; PROTEIN BINDING; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANTIBODIES, MONOCLONAL; HUMANS; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY;

EID: 79953776654     PISSN: 09523499     EISSN: 10991352     Source Type: Journal    
DOI: 10.1002/jmr.1069     Document Type: Article

References (25)

1. Bard F, Cannon C, Barbour R, Burke RR, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Lieberburg I, Motter R, Nguyen M, Soriano F, Vasquez N, Weiss K, Welch B, Seubert P, Schenk D, Yednock T,. 2000. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer's disease. Nat. Med. 6: 916-919. (Pubitemid 30644751)
2. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE,. 2000. The Protein Data Bank. Nucleic Acids Res. 28: 235-242. (Pubitemid 30047768)
3. Collaborative Computational Project, Number 4. 1994. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D50: 760-763.
4. Citron M,. 2004. Strategies for disease modification in Alzheimer's disease. Nat. Rev. 5: 677-685. (Pubitemid 39150139)
5. DeMattos RB, Bales KR, Cummins DJ, Dodart J-C, Paul SM, Holtzman DM,. 2001. Peripheral anti-Aβ antibody alters CNS and plasma A beta clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 98: 8850-8855. (Pubitemid 32678116)
6. Dineley KT, Westerman M, Bui D, Bell K, Ashe KH, Sweatt JD,. 2001. β-Amyloid activates the mitogen-activated protein kinase cascade via hippocampal α7 nicotinic acetylcholine receptors: in vitro and in vivo mechanisms related to Alzheimer's disease. J. Neurosci. 21: 4125-4133. (Pubitemid 32538537)
7. Emsley P, Cowtan K,. 2004. Coot: model building tools for molecular graphics. Acta Crystallogr. D60: 2126-2132. (Pubitemid 41742764)
8. Gardberg AS, Dice LT, Ou S, Rich RL, Helmbrecht E, Ko J, Wetzel R, Myszka DG, Patterson PH, Dealwis C,. 2007. Molecular basis for passive immunotherapy of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 104: 15659-15664. (Pubitemid 350035356)
9. Golde TE,. 2003. Alzheimer disease therapy: can the amyloid cascade be halted? J. Clin. Invest. 111: 11-18. (Pubitemid 36134840)
10. Hardy JA, Higgins GA,. 1992. Alzheimer's disease: the amyloid cascade hypothesis. Science 256: 184-185.
11. Ireton GC, Stoddard BL,. 2004. Microseed matrix screening to improve crystals of yeast cytosine deaminase. Acta Crystallogr. D60: 601-605. (Pubitemid 41087611)
12. Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD, Chishti MA, Horne P, Heslin D, French J, Mount HTJ, Nixon RA, Mercken M, Bergeron C, Fraser PE, St. George-Hyslop P, Westaway D,. 2000. Aβ-peptide immunization reduces behavioral impairment and plaques in a model of Alzheimer's disease. Nature 408: 979-982. (Pubitemid 32101644)
13. Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C,. 1991. Sequences of Proteins of Immunological Interest. NIH Publication No. 91-3242. US Department of Health and Human Services: Washington, DC.
14. Liu Q, Huang Y, Xue F, Simard A, DeChon J, Li G, Zhang J, Lucer L, Wang M, Sierks M, Hu G, Chang Y, Lukas RJ, Wu J,. 2009. A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides. J. Neurosci. 29: 918-929.
15. Mattson MP,. 2004. Pathways towards and away from Alzheimer's disease. Nature 430: 631-639. (Pubitemid 39061671)
16. Miles LA, Wun KS, Crespi GA, Fodero-Tavoletti MT, Galatis D, Bagley CJ, Beyreuther K, Masters CL, Cappai R, McKinstry WJ, Barnham KJ, Parker MW,. 2008. Amyloid-β-anti-amyloid-β complex structure reveals an extended conformation in the immunodominant B-cell epitope. J. Mol. Biol. 377: 181-192.
17. Murshudov GN, Vagin AA, Dodson EJ,. 1997. Refinement of macromolecular structures by maximum-likelihood method. Acta Crystallogr. D53: 240-255. (Pubitemid 27235885)
18. Neugroschl J, Sano M,. 2010. Current treatment and recent clinical research in Alzheimer's disease. Mt. Sinai J. Med. 77: 3-16.
19. 1-42 peptide directly modulates nicotinic receptors in the rat hippocampal slice. J. Neurosci. 21: RC120.
20. Read RJ,. 2001. Pushing the boundaries of molecular replacement with maximum likelihood. Acta Crystallogr. D57: 1373-1382. (Pubitemid 36117185)
21. Robert R, Streltsov VA, Newman J, Pearce LA, Wark KL, Dolezal O,. 2010. Germline humanization of a murine Aβ antibody and crystal structure of the humanized recombinant Fab fragment. Protein Sci. 19: 299-308.
22. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P,. 1999. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in PDAPP mouse. Nature 400: 173-177. (Pubitemid 29327547)
23. Selkoe DJ,. 2001. Alzheimer's disease: genes, proteins and therapy. Physiol. Rev. 81: 741-766. (Pubitemid 32267077)
24. Selkoe DJ, Podlisny MB,. 2002. Deciphering the genetic basis of Alzheimer's disease. Annu. Rev. Genomics Hum. Genet. 3: 67-99. (Pubitemid 35217431)
25. Weiner HL, Lemere CA, Maron R, Spooner ET, Grenfell TJ, Mori C, Issazadeh S, Hancock WW, Selkoe DJ,. 2000. Nasal administration of amyloid-β peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease. Ann. Neurol. 48: 567-579.